– USA, CA – Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the appointments of Joseph Giles and Christina LaMontagne to its Board as independent directors.
“Joseph and Christina both have deep roots in healthcare and bring extensive experience in growing and scaling companie. Zerigo Health is extremely fortunate to have them join our Board of Directors. Their insights and direction will be paramount as we continue expanding our services to members with chronic skin conditions and those who pay for their cares,” said CEO John Schellhorn.
“I look forward to partnering with Christina, Joseph, and the rest of our Board Members to help rapidly transform treatment options for consumers with chronic skin conditions,” added Executive Chairman Glen Tullman. “Zerigo Health is empowering people to better manage their chronic skin conditions from the comfort of home or any location they choose, while also helping to significantly reduce costs associated with legacy treatment methods and expensive therapeutics.”
About Joseph E. Giles
Most recently, Mr. Giles served as Founder and CEO of Midwest Vision Partners, one of the fastest-growing ophthalmology and optometry practices in the US. Prior to founding MVP, Mr. Giles served as COO at Athletico Physical Therapy, the third largest physical therapy company in the US. He also brings extensive banking and investing experience, having worked for Vista Equity Partners, Barclays, Credit Suisse, and Goldman Sachs.
“Zerigo Health’s innovative approach to treating various skin conditions has significantly advanced dermatological care and meaningfully improved patient outcomes and experiences. I am excited to join the Zerigo Health Board and partner with the amazing leadership team they have assembled,” said Joseph Giles.
Mr. Giles is a certified public accountant and licensed attorney, having earned a Bachelor of Business Administration, a Master of Business Administration and a Juris Doctor from the University of Michigan.
About Christina LaMontagne
Ms. LaMontagne is the former COO of leading women’s telehealth provider, Pill Club. She has been immersed in digital health for over a decade, leading digital corporate development at Johnson & Johnson, building health insurance tools at Nerdwallet, and serving as an investor and advisor to numerous pioneering digital health start-ups.
Ms. LaMontagne earned a Bachelor’s Degree in Asian Studies from Dartmouth College and a Master of Business Administration from Harvard Business School. She was also a Fulbright Scholar in China.
“I’m thrilled to support Zerigo Health’s continued growth as a category-defining leader in delivering accessible chronic skin condition treatment. Zerigo is dramatically improving the patient experience, ultimately leading to significant improvements in outcomes and overall health for patients,” said Christina LaMontagne.
About Zerigo Health
Zerigo Health offers the only comprehensive home solution that seamlessly connects patients and providers to deliver optimal dermatological outcomes. Zerigo’s precision solution remotely treats and monitors patients with chronic skin conditions using narrowband ultraviolet B phototherapy, a proven, standard-of-care treatment. Patients benefit from the unique combination of advanced technology with personal coaching and support throughout their treatment journey, which results in documented increases in treatment adherence and patient satisfaction.
For more information : https://www.zerigohealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
